Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,766

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa

Open access
Lipsky, Benjamin A., Berendt, Anthony R., Cornia, Paul B., Pile, James C., Peters, Edgar J. G., Armstrong, David G., Deery, H. Gunner, Embil, John M., Joseph, Warren S., Karchmer, Adolf W., Pinzur, Michael S., Senneville, Eric·2012·Clinical Infectious Diseases
DOI 10.1093/cid/cis346
Open this paper in CoChat — free account

Abstract

Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infection is defined by ≥2 classic findings of inflammation or purulence. Infections are then classified into mild (superficial and limited in size and depth), moderate (deeper or more extensive), or severe (accompanied by systemic signs or metabolic perturbations). This classification system, along with a vascular assessment, helps determine which patients should be hospitalized, which may require special imaging procedures or surgical interventions, and which will require amputation. Most DFIs are polymicrobial, with aerobic gram-positive cocci (GPC), and especially staphylococci, the most common causative organisms. Aerobic gram-negative bacilli are frequently copathogens in infections that are chronic or follow antibiotic treatment, and obligate anaerobes may be copathogens in ischemic or necrotic wounds. Wounds without evidence of soft tissue or bone infection do not require antibiotic therapy. For infected wounds, obtain a post-debridement specimen (preferably of tissue) for aerobic and anaerobic culture. Empiric antibiotic therapy can be narrowly targeted at GPC in many acutely infected patients, but those at risk for infection with antibiotic-resistant organisms or with chronic, previously treated, or severe infections usually require broader spectrum regimens. Imaging is helpful in most DFIs; plain radiographs may be sufficient, but magnetic resonance imaging is far more sensitive and specific. Osteomyelitis occurs in many diabetic patients with a foot wound and can be difficult to diagnose (optimally defined by bone culture and histology) and treat (often requiring surgical debridement or resection, and/or prolonged antibiotic therapy). Most DFIs require some surgical intervention, ranging from minor (debridement) to major (resection, amputation). Wounds must also be properly dressed and off-loaded of pressure, and patients need regular follow-up. An ischemic foot may require revascularization, and some nonresponding patients may benefit from selected adjunctive measures. Employing multidisciplinary foot teams improves outcomes. Clinicians and healthcare organizations should attempt to monitor, and thereby improve, their outcomes and processes in caring for DFIs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cis346

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 332

  1. Guyatt, 2008, Going from evidence to recommendations, BMJ, 336, 1049, 10.1136/bmj.39493.646875.AE · DOI · Paper page
  2. Kish, 2001, Guide to development of practice guidelines, Clin Infect Dis, 32, 851, 10.1086/319366 · DOI · Paper page
  3. Guyatt, 2008, Incorporating considerations of resources use into grading recommendations, BMJ, 336, 1170, 10.1136/bmj.39504.506319.80 · DOI
  4. Centers for Disease Control and Prevention, 2010, Number (in thousands) of hospital discharges with ulcer/inflammation/infection (ULCER) as first-listed diagnosis and diabetes as any-listed diagnosis, 1980–2003
  5. Centers for Disease Control and Prevention, 2010, Number (in thousands) of hospital discharges for non-traumatic lower extremity amputation with diabetes as a listed diagnosis, 1988–2006
  6. Vamos, 2010, Trends in lower extremity amputations in people with and without diabetes in England, 1996–2005, Diabetes Res Clin Pract, 87, 275, 10.1016/j.diabres.2009.11.016 · DOI
  7. Richard, 2010, Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study, Diabetes Metab, 37, 208, 10.1016/j.diabet.2010.10.003 · DOI
  8. Prompers, 2007, High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study, Diabetologia, 50, 18, 10.1007/s00125-006-0491-1 · DOI · Paper page
  9. Prompers, 2008, Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study, Diabetologia, 51, 747, 10.1007/s00125-008-0940-0 · DOI · Paper page
  10. van Battum, 2011, Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation, Diabet Med, 28, 199, 10.1111/j.1464-5491.2010.03192.x · DOI
  11. Prompers, 2008, Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study, Diabetologia, 51, 1826, 10.1007/s00125-008-1089-6 · DOI · Paper page
  12. Prompers, 2008, Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study, Diabet Med, 25, 700, 10.1111/j.1464-5491.2008.02445.x · DOI
  13. Gottrup, 2001, A new concept of a multidisciplinary wound healing center and a national expert function of wound healing, Arch Surg, 136, 765, 10.1001/archsurg.136.7.765 · DOI
  14. Trautner, 2007, Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990–2005: results of the Leverkusen Amputation Reduction Study (LARS), Diabetes Care, 30, 2633, 10.2337/dc07-0876 · DOI
  15. Krishnan, 2008, Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit, Diabetes Care, 31, 99, 10.2337/dc07-1178 · DOI
  16. Hellingman, 2008, Efficacy and efficiency of a streamlined multidisciplinary foot ulcer service, J Wound Care, 17, 541, 10.12968/jowc.2008.17.12.31764 · DOI
  17. Rerkasem, 2008, Reducing lower extremity amputations due to diabetes: the application of diabetic-foot protocol in Chiang Mai University Hospital, Int J low Extrem Wounds, 7, 88, 10.1177/1534734608317939 · DOI
  18. Ortegon, 2004, Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis, Diabetes Care, 27, 901, 10.2337/diacare.27.4.901 · DOI
  19. Tan, 2011, Inpatient management of diabetic foot problems: summary of NICE guidance, BMJ, 342, d1280, 10.1136/bmj.d1280 · DOI
  20. Singh, 2005, Preventing foot ulcers in patients with diabetes, JAMA, 293, 217, 10.1001/jama.293.2.217 · DOI
  21. Haller, 2009, Patient computer use to prompt doctor adherence to diabetes management guidelines, J Eval Clin Pract, 15, 1118, 10.1111/j.1365-2753.2009.01264.x · DOI
  22. Field, 1990, Clinical Practice Guidelines: directions for a new program, 52, 10.17226/1626 · DOI · Paper page
  23. Guyatt, 2008, Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed, Chest, 133, 123S, 10.1378/chest.08-0654 · DOI
  24. Cutting, 2004, Defined and refined: criteria for identifying wound infection revisited, Br J Community Nurs, 9, S6, 10.12968/bjcn.2004.9.Sup1.12495 · DOI
  25. Gardner, 2009, Clinical signs of infection in diabetic foot ulcers with high microbial load, Biol Res Nurs, 11, 119, 10.1177/1099800408326169 · DOI
  26. Lavery, 2006, Risk factors for foot infections in individuals with diabetes, Diabetes Care, 29, 1288, 10.2337/dc05-2425 · DOI · Paper page
  27. Peters, 2005, Diabetic lower extremity infection: influence of physical, psychological, and social factors, J Diabetes Complications, 19, 107, 10.1016/j.jdiacomp.2004.06.002 · DOI
  28. Bartos, 1997, [Risk factors for diabetic foot in recipients of renal and pancreatic transplants], Cas Lek Cesk, 136, 527
  29. George, 2004, An audit of foot infections in patients with diabetes mellitus following renal transplantation, Int J low Extrem Wounds, 3, 157, 10.1177/1534734604267768 · DOI
  30. Hill, 1996, Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study, ANNA J, 23, 381
  31. Jayasinghe, 2007, Is walking barefoot a risk factor for diabetic foot disease in developing countries?, Rural Remote Health, 7, 692
  32. Karthikesalingam, 2010, A systematic review of scoring systems for diabetic foot ulcers, Diabet Med, 27, 544, 10.1111/j.1464-5491.2010.02989.x · DOI
  33. Schaper, 2004, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies, Diabetes Metab Res Rev, 20, S90, 10.1002/dmrr.464 · DOI
  34. Meggitt, 1976, Surgical management of the diabetic foot, Br J Hosp Med, 16, 227
  35. Ince, 2008, Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents, Diabetes Care, 31, 964, 10.2337/dc07-2367 · DOI
  36. Lavery, 2007, Validation of the Infectious Diseases Society of America's diabetic foot infection classification system, Clin Infect Dis, 44, 562, 10.1086/511036 · DOI · Paper page
  37. Jeandrot, 2008, Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study, Diabetologia, 51, 347, 10.1007/s00125-007-0840-8 · DOI
  38. Wagner, 1981, The dysvascular foot: a system for diagnosis and treatment, Foot Ankle, 2, 64, 10.1177/107110078100200202 · DOI
  39. Treece, 2004, Validation of a system of foot ulcer classification in diabetes mellitus, Diabet Med, 21, 987, 10.1111/j.1464-5491.2004.01275.x · DOI
  40. Ince, 2007, The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes, Diabet Med, 24, 977, 10.1111/j.1464-5491.2007.02189.x · DOI
  41. Armstrong, 1998, Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation, Diabetes Care, 21, 855, 10.2337/diacare.21.5.855 · DOI
  42. Parisi, 2008, Comparison of three systems of classification in predicting the outcome of diabetic foot ulcers in a Brazilian population, Eur J Endocrinol, 159, 417, 10.1530/EJE-07-0841 · DOI
  43. Knighton, 1986, Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF), Ann Surg, 204, 322, 10.1097/00000658-198609000-00011 · DOI · Paper page
  44. Beckert, 2006, A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients, Diabetes Care, 29, 988, 10.2337/dc05-2431 · DOI
  45. Beckert, 2009, M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds, Ann Surg, 249, 677, 10.1097/SLA.0b013e31819eda06 · DOI
  46. Lipsky, 2009, The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial, Wound Repair Regen, 17, 671, 10.1111/j.1524-475X.2009.00521.x · DOI
  47. Lipsky, 2004, Diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 39, 885, 10.1086/424846 · DOI · Paper page
  48. Schaper, 2003, The international consensus and practical guidelines on the management and prevention of the diabetic foot, Curr Diab Rep, 3, 475, 10.1007/s11892-003-0010-4 · DOI
  49. Shah, 2003, Quantifying the risk of infectious diseases for people with diabetes, Diabetes Care, 26, 510, 10.2337/diacare.26.2.510 · DOI
  50. Vedhara, 2010, Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence, Diabetologia, 53, 1590, 10.1007/s00125-010-1743-7 · DOI
  51. Uzun, 2007, Procalcitonin as a diagnostic aid in diabetic foot infections, Tohoku J Exp Med, 213, 305, 10.1620/tjem.213.305 · DOI
  52. Lipsky, 2007, Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial, Int Wound J, 4, 30, 10.1111/j.1742-481X.2006.00274.x · DOI
  53. Akinci, 2011, Acute phase reactants predict the risk of amputation in diabetic foot infection, J Am Podiatr Med Assoc, 101, 1, 10.7547/1010001 · DOI
  54. 2003, Peripheral arterial disease in people with diabetes, Diabetes Care, 26, 3333, 10.2337/diacare.26.12.3333 · DOI · Paper page
  55. van Baal, 2004, Surgical treatment of the infected diabetic foot, Clin Infect Dis, 39, S123, 10.1086/383273 · DOI
  56. Pinzur, 2003, Controversies in amputation surgery, Instr Course Lect, 52, 445
  57. Khan, 2006, Does the clinical examination predict lower extremity peripheral arterial disease?, JAMA, 295, 536, 10.1001/jama.295.5.536 · DOI
  58. Wilson, 2007, In the clinic. Peripheral arterial disease, Ann Intern Med, 146, ITC3-1, 10.7326/0003-4819-146-5-200703060-01003 · DOI
  59. Crane, 1999, Critical pathway approach to diabetic pedal infections in a multidisciplinary setting, J Foot Ankle Surg, 38, 30, 10.1016/S1067-2516(99)80085-4 · DOI
  60. Larsson, 1995, Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?, Diabet Med, 12, 770, 10.1111/j.1464-5491.1995.tb02078.x · DOI
  61. Dargis, 1999, Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study, Diabetes Care, 22, 1428, 10.2337/diacare.22.9.1428 · DOI
  62. Fitzgerald, 2009, The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage, Eplasty, 9, e15
  63. Gibbons, 2003, Lower extremity bypass in patients with diabetic foot ulcers, Surg Clin North Am, 83, 659, 10.1016/S0039-6109(02)00199-8 · DOI
  64. Bus, 2010, Assessment of foot disease in the home environment of diabetic patients using a new photographic foot imaging device, J Med Eng Technol, 34, 43, 10.3109/03091900903336894 · DOI
  65. Clemensen, 2005, Telemedical treatment at home of diabetic foot ulcers, J Telemed Telecare, 11, S14, 10.1258/135763305775124830 · DOI
  66. Bowling, 2011, Remote assessment of diabetic foot ulcers using a novel wound imaging system, Wound Repair Regen, 19, 25, 10.1111/j.1524-475X.2010.00645.x · DOI
  67. Wilbright, 2004, The use of telemedicine in the management of diabetes-related foot ulceration: a pilot study, Adv Skin Wound Care, 17, 232, 10.1097/00129334-200406000-00012 · DOI
  68. Aragon-Sanchez, 2011, Seminar review: a review of the basis of surgical treatment of diabetic foot infections, Int J Low Extrem Wounds, 10, 33, 10.1177/1534734611400259 · DOI
  69. Sumpio, 2010, The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association, J Vasc Surg, 51, 1504, 10.1016/j.jvs.2010.04.010 · DOI
  70. Akbari, 2000, Lower extremity revascularization in diabetes: late observations, Arch Surg, 135, 452, 10.1001/archsurg.135.4.452 · DOI
  71. Lipsky, 1990, Outpatient management of uncomplicated lower-extremity infections in diabetic patients, Arch Intern Med, 150, 790, 10.1001/archinte.1990.00390160058013 · DOI
  72. Lipsky, 2004, Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate, Clin Infect Dis, 38, 17, 10.1086/380449 · DOI
  73. Armstrong, 1996, Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus, J Foot Ankle Surg, 35, 280, 10.1016/S1067-2516(96)80075-5 · DOI
  74. Eneroth, 1999, Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis, J Diabetes Complications, 13, 254, 10.1016/S1056-8727(99)00065-3 · DOI
  75. Frykberg, 2003, An evidence-based approach to diabetic foot infections, Am J Surg, 186, 44S, 10.1016/j.amjsurg.2003.10.008 · DOI
  76. Caputo, 1994, Assessment and management of foot disease in patients with diabetes, N Engl J Med, 331, 854, 10.1056/NEJM199409293311307 · DOI
  77. No authors listed, 1999, Consensus Development Conference on Diabetic Foot Wound Care: 7–8 April 1999, Boston, Massachusetts. American Diabetes Association, Diabetes Care, 22, 1354, 10.2337/diacare.22.8.1354 · DOI
  78. Rao, 2007, Optimising antimicrobial therapy in diabetic foot infections, Drugs, 67, 195, 10.2165/00003495-200767020-00003 · DOI
  79. Dang, 2003, Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem, Diabet Med, 20, 159, 10.1046/j.1464-5491.2003.00860.x · DOI
  80. Carvalho, 2004, [Diabetic foot infection. Bacteriologic analysis of 141 patients], Arq Bras Endocrinol Metabol, 48, 398, 10.1590/S0004-27302004000300012 · DOI
  81. Shankar, 2005, Bacterial etiology of diabetic foot infections in South India, Eur J Intern Med, 16, 567, 10.1016/j.ejim.2005.06.016 · DOI
  82. Tascini, 2006, Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis, J Chemother, 18, 648, 10.1179/joc.2006.18.6.648 · DOI
  83. Kandemir, 2007, Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms, J Infect, 54, 439, 10.1016/j.jinf.2006.08.013 · DOI
  84. Gadepalli, 2006, A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital, Diabetes Care, 29, 1727, 10.2337/dc06-0116 · DOI
  85. Edmonds, 2005, Infection in the neuroischemic foot, Int J low Extrem Wounds, 4, 145, 10.1177/1534734605280597 · DOI
  86. Richard, 2008, Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers, Diabetes Metab, 34, 363, 10.1016/j.diabet.2008.02.005 · DOI
  87. Sotto, 2007, Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers, Diabetes Care, 30, 2051, 10.2337/dc07-0461 · DOI
  88. Chakraborti, 2010, Sensitivity of superficial cultures in lower extremity wounds, J Hosp Med, 5, 415, 10.1002/jhm.688 · DOI
  89. Gardner, 2006, Diagnostic validity of three swab techniques for identifying chronic wound infection, Wound Repair Regen, 14, 548, 10.1111/j.1743-6109.2006.00162.x · DOI
  90. Nelson, 2006, A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers, Health Technol Assess, 10, 10.3310/hta10120 · DOI
  91. Singh, 2009, Detecting aerobic bacterial diversity in patients with diabetic foot wounds using ERIC-PCR: a preliminary communication, Int J Low Extrem Wounds, 8, 203, 10.1177/1534734609353080 · DOI
  92. Fisher, 2010, Diabetic foot infections: a need for innovative assessments, Int J Low Extrem Wounds, 9, 31, 10.1177/1534734610363459 · DOI
  93. Sotto, 2008, Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm, Diabetes Care, 31, 2318, 10.2337/dc08-1010 · DOI
  94. Wolcott, 2010, Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics, J Wound Care, 19, 272, 10.12968/jowc.2010.19.7.48898 · DOI
  95. Hirschl, 1992, Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone, Chemotherapy, 38, 275, 10.1159/000239012 · DOI
  96. Chantelau, 1996, Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial, Diabet Med, 13, 156, 10.1002/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO;2-U · DOI
  97. Edmonds, 2004, The use of antibiotics in the diabetic foot, Am J Surg, 187, 25S, 10.1016/S0002-9610(03)00300-3 · DOI
  98. Gardner, 2008, Wound bioburden and infection-related complications in diabetic foot ulcers, Biol Res Nurs, 10, 44, 10.1177/1099800408319056 · DOI
  99. Ramakant, 2011, Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?, Diabetologia, 54, 58, 10.1007/s00125-010-1893-7 · DOI
  100. Lipsky, 2007, Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?, Clin Microbiol Infect, 13, 351, 10.1111/j.1469-0691.2007.01697.x · DOI
  101. Wheat, 1986, Diabetic foot infections. Bacteriologic analysis, Arch Intern Med, 146, 1935, 10.1001/archinte.1986.00360220079017 · DOI
  102. Krikava, 1999, [The diabetic foot syndrome—antibiotic therapy], Rozhl Chir, 78, 295
  103. Ng, 2008, Anaerobic culture of diabetic foot infections: organisms and antimicrobial susceptibilities, Ann Acad Med Singapore, 37, 936, 10.47102/annals-acadmedsg.V37N11p936 · DOI
  104. Dowd, 2008, Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP), PLoS One, 3, e3326, 10.1371/journal.pone.0003326 · DOI · Paper page
  105. Armstrong, 1995, Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections, J Am Podiatr Med Assoc, 85, 533, 10.7547/87507315-85-10-533 · DOI
  106. Lipsky, 2008, Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream, Clin Infect Dis, 47, 1537, 10.1086/593185 · DOI
  107. Lipsky, 2009, Topical antimicrobial therapy for treating chronic wounds, Clin Infect Dis, 49, 1541, 10.1086/644732 · DOI · Paper page
  108. Lipsky, 1997, Treatment of infected diabetic foot ulcers: topical MSI-78 vs. oral ofloxacin, Diabetologia, 40, 482
  109. Noel, 2008, Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria, Antimicrob Agents Chemother, 52, 37, 10.1128/AAC.00551-07 · DOI
  110. Noel, 2008, A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections, Clin Infect Dis, 46, 647, 10.1086/526527 · DOI
  111. Graham, 2002, Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study, Clin Infect Dis, 34, 1460, 10.1086/340348 · DOI
  112. Lipsky, 2005, Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial, Lancet, 366, 1695, 10.1016/S0140-6736(05)67694-5 · DOI
  113. Ertugrul, 2008, Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections, J Am Podiatr Med Assoc, 98, 290, 10.7547/0980290 · DOI
  114. Martinez-Gomez, 2009, [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms], Enferm Infecc Microbiol Clin, 27, 317
  115. Bansal, 2008, Spectrum of microbial flora in diabetic foot ulcers, Indian J Pathol Microbiol, 51, 204, 10.4103/0377-4929.41685 · DOI
  116. Yoga, 2006, Bacteriology of diabetic foot lesions, Med J Malaysia, 61, 14
  117. Shakil, 2010, Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study, Ann Clin Microbiol Antimicrob, 9, 2, 10.1186/1476-0711-9-2 · DOI
  118. Wang, 2010, Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence, J Med Microbiol, 59, 1219, 10.1099/jmm.0.020537-0 · DOI
  119. Tentolouris, 2006, Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers, Clin Microbiol Infect, 12, 186, 10.1111/j.1469-0691.2005.01279.x · DOI
  120. Yates, 2009, Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers, Diabetes Care, 32, 1907, 10.2337/dc09-0295 · DOI
  121. Vardakas, 2008, Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials, Diabetes Res Clin Pract, 80, 344, 10.1016/j.diabres.2008.01.009 · DOI
  122. Arbeit, 2004, The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections, Clin Infect Dis, 38, 1673, 10.1086/420818 · DOI
  123. Eleftheriadou, 2010, Methicillin-resistant Staphylococcus aureus in diabetic foot infections, Drugs, 70, 1785, 10.2165/11538070-000000000-00000 · DOI
  124. Liu, 2011, Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children, Clin Infect Dis, 52, e18, 10.1093/cid/ciq146 · DOI
  125. David, 2008, What is community-associated methicillin-resistant Staphylococcus aureus?, J Infect Dis, 197, 1235, 10.1086/533502 · DOI
  126. Lagace-Wiens, 2009, The diabetic foot clinic: not a significant source for acquisition of methicillin-resistant Staphylococcus aureus, Am J Infect Control, 37, 587, 10.1016/j.ajic.2008.11.006 · DOI
  127. Raymakers, 1998, Penetration of ceftazidime into bone from severely ischaemic limbs, J Antimicrob Chemother, 42, 543, 10.1093/jac/42.4.543 · DOI
  128. Seabrook, 1991, Comparison of serum and tissue antibiotic levels in diabetes-related foot infections, Surgery, 110, 671
  129. Duckworth, 1993, Tissue penetration of clindamycin in diabetic foot infections, J Antimicrob Chemother, 31, 581, 10.1093/jac/31.4.581 · DOI
  130. Legat, 2003, Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome, Antimicrob Agents Chemother, 47, 371, 10.1128/AAC.47.1.371-374.2003 · DOI
  131. Muller, 1999, Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients, Antimicrob Agents Chemother, 43, 2056, 10.1128/AAC.43.8.2056 · DOI
  132. Kuck, 1998, Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections, Foot Ankle Int, 19, 38, 10.1177/107110079801900107 · DOI
  133. Mueller-Buehl, 1991, Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease, Vasa, 20, 17
  134. Traunmuller, 2010, Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections, J Antimicrob Chemother, 65, 1252, 10.1093/jac/dkq109 · DOI
  135. Schintler, 2009, High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection, J Antimicrob Chemother, 64, 574, 10.1093/jac/dkp230 · DOI
  136. Majcher-Peszynska, 2008, Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections, Eur J Clin Pharmacol, 64, 1093, 10.1007/s00228-008-0531-5 · DOI
  137. Nicolau, 2010, Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics, J Am Podiatr Med Assoc, 100, 52, 10.7547/1000052 · DOI
  138. Raymakers, 2001, The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb, Diabet Med, 18, 229, 10.1046/j.1464-5491.2001.00460.x · DOI
  139. Deresinski, 2008, The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials, Diagn Microbiol Infect Dis, 61, 103, 10.1016/j.diagmicrobio.2008.03.004 · DOI
  140. Lipsky, 2007, Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate, J Antimicrob Chemother, 60, 370, 10.1093/jac/dkm130 · DOI
  141. Harkless, 2005, An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers, Surg Infect (Larchmt), 6, 27, 10.1089/sur.2005.6.27 · DOI
  142. Clay, 2004, Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males, Am J Geriatr Pharmacother, 2, 181, 10.1016/j.amjopharm.2004.09.006 · DOI
  143. Lobmann, 2004, Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones, Diabetes Nutr Metab, 17, 156
  144. Vick-Fragoso, 2009, Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections, Infection, 37, 407, 10.1007/s15010-009-8468-x · DOI
  145. Griffis, 2009, The use of gentamycin-impregnated foam in the management of diabetic foot infections: a promising delivery system?, Expert Opin Drug Deliv, 6, 639, 10.1517/17425240902997919 · DOI
  146. Salgami, 2007, Use of tobramycin-impregnated calcium sulphate pellets in addition to oral antibiotics: an alternative treatment to minor amputation in a case of diabetic foot osteomyelitis, Diabetes Care, 30, 181, 10.2337/dc06-1792 · DOI
  147. Lipsky, 2005, Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections, J Antimicrob Chemother, 55, 240, 10.1093/jac/dkh531 · DOI
  148. Saltoglu, 2010, Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital, Clin Microbiol Infect, 16, 1252, 10.1111/j.1469-0691.2009.03067.x · DOI
  149. Lipsky, 1999, Evidence-based antibiotic therapy of diabetic foot infections, FEMS Immunol Med Microbiol, 26, 267, 10.1111/j.1574-695X.1999.tb01398.x · DOI
  150. Crouzet, 2011, Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy, Int J Infect Dis, 15, e601, 10.1016/j.ijid.2011.05.003 · DOI
  151. Dinh, 2008, Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis, Clin Infect Dis, 47, 519, 10.1086/590011 · DOI
  152. Shults, 1989, Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers, Am J Surg, 158, 525, 10.1016/0002-9610(89)90184-0 · DOI
  153. Butalia, 2008, Does this patient with diabetes have osteomyelitis of the lower extremity?, JAMA, 299, 806, 10.1001/jama.299.7.806 · DOI · Paper page
  154. Jeffcoate, 2004, Controversies in diagnosing and managing osteomyelitis of the foot in diabetes, Clin Infect Dis, 39, S115, 10.1086/383272 · DOI
  155. Kapoor, 2007, Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis, Arch Intern Med, 167, 125, 10.1001/archinte.167.2.125 · DOI
  156. Ledermann, 2002, Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging, Radiology, 224, 649, 10.1148/radiol.2243011231 · DOI
  157. Ledermann, 2002, Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess, AJR Am J Roentgenol, 178, 215, 10.2214/ajr.178.1.1780215 · DOI
  158. Schweitzer, 2004, MR imaging of the diabetic foot, Radiol Clin North Am, 42, 61, 10.1016/S0033-8389(03)00163-5 · DOI
  159. Tan, 2007, MRI of the diabetic foot: differentiation of infection from neuropathic change, Br J Radiol, 80, 939, 10.1259/bjr/30036666 · DOI
  160. Tomas, 2000, The diabetic foot, Br J Radiol, 73, 443, 10.1259/bjr.73.868.10844873 · DOI
  161. Armstrong, 1998, Outcomes of preventative care in a diabetic foot specialty clinic, J Foot Ankle Surg, 37, 460, 10.1016/S1067-2516(98)80022-7 · DOI
  162. Becker, 1999, Imaging osteomyelitis and the diabetic foot, Q J Nucl Med, 43, 9
  163. Palestro, 2009, Nuclear medicine and diabetic foot infections, Semin Nucl Med, 39, 52, 10.1053/j.semnuclmed.2008.08.006 · DOI
  164. Delcourt, 2005, Comparison between Leukoscan (Sulesomab) and Gallium-67 for the diagnosis of osteomyelitis in the diabetic foot, Diabetes Metab, 31, 125, 10.1016/S1262-3636(07)70178-7 · DOI
  165. Schweitzer, 2008, ACR Appropriateness criteria on suspected osteomyelitis in patients with diabetes mellitus, J Am Coll Radiol, 5, 881, 10.1016/j.jacr.2008.05.002 · DOI
  166. Enderle, 1999, Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound, Diabetes Care, 22, 294, 10.2337/diacare.22.2.294 · DOI
  167. Keidar, 2005, The diabetic foot: initial experience with 18F-FDG PET/CT, J Nucl Med, 46, 444
  168. Basu, 2007, Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?, Nucl Med Commun, 28, 465, 10.1097/MNM.0b013e328174447f · DOI
  169. Nawaz, 2010, Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot, Mol Imaging Biol, 12, 335, 10.1007/s11307-009-0268-2 · DOI
  170. Heiba, 2010, The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol, J Foot Ankle Surg, 49, 529, 10.1053/j.jfas.2010.07.010 · DOI
  171. Sella, 2009, Current concepts review: diagnostic imaging of the diabetic foot, Foot Ankle Int, 30, 568, 10.3113/FAI.2009.0568 · DOI
  172. Berendt, 2004, Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot, Curr Diab Rep, 4, 424, 10.1007/s11892-004-0051-3 · DOI
  173. Ahmadi, 2006, Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics, Radiology, 238, 622, 10.1148/radiol.2382041393 · DOI
  174. Berendt, 2008, Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment, Diabetes Metab Res Rev, 24, S145, 10.1002/dmrr.836 · DOI
  175. Lipsky, 1997, Osteomyelitis of the foot in diabetic patients, Clin Infect Dis, 25, 1318, 10.1086/516148 · DOI
  176. Snyder, 2001, Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 2: medical, surgical, and alternative treatments, Ostomy Wound Manage, 47, 24
  177. Snyder, 2001, Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 1: overview, diagnosis, and microbiology, Ostomy Wound Manage, 47, 18
  178. Embil, 2000, The management of diabetic foot osteomyelitis, The Diabetic Foot, 3, 76
  179. Eckman, 1995, Foot infections in diabetic patients. Decision and cost-effectiveness analyses, JAMA, 273, 712, 10.1001/jama.1995.03520330042035 · DOI
  180. Lipsky, 2004, A report from the international consensus on diagnosing and treating the infected diabetic foot, Diabetes Metab Res Rev, 20, S68, 10.1002/dmrr.453 · DOI
  181. Chantelau, 2007, Bone histomorphology may be unremarkable in diabetes mellitus, Med Klin (Munich), 102, 429, 10.1007/s00063-007-1055-y · DOI
  182. Newman, 1991, Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline, JAMA, 266, 1246, 10.1001/jama.1991.03470090080036 · DOI
  183. Lavery, 2009, Risk factors for developing osteomyelitis in patients with diabetic foot wounds, Diabetes Res Clin Pract, 83, 347, 10.1016/j.diabres.2008.11.030 · DOI
  184. Fleischer, 2009, Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot, J Foot Ankle Surg, 48, 39, 10.1053/j.jfas.2008.09.003 · DOI
  185. Rajbhandari, 2000, ‘Sausage toe’: a reliable sign of underlying osteomyelitis, Diabet Med, 17, 74, 10.1046/j.1464-5491.2000.00194.x · DOI
  186. Grayson, 1995, Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients, JAMA, 273, 721, 10.1001/jama.1995.03520330051036 · DOI
  187. Shone, 2006, Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes, Diabetes Care, 29, 945, 10.2337/diacare.29.04.06.dc05-2450 · DOI
  188. Lavery, 2007, Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic?, Diabetes Care, 30, 270, 10.2337/dc06-1572 · DOI
  189. Hartemann-Heurtier, 2008, Diabetic foot osteomyelitis, Diabetes Metab, 34, 87, 10.1016/j.diabet.2007.09.005 · DOI
  190. Aragon-Sanchez, 2011, Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?, Diabet Med, 28, 191, 10.1111/j.1464-5491.2010.03150.x · DOI
  191. Morales Lozano, 2010, Validating the probe-to-bone and other tests for diagnosing chronic osteomyelitis in the diabetic foot, Diabetes Care, 33, 2140, 10.2337/dc09-2309 · DOI
  192. Lavery, 1996, Classification of diabetic foot wounds, J Foot Ankle Surg, 35, 528, 10.1016/S1067-2516(96)80125-6 · DOI
  193. Wheat, 1985, Diagnostic strategies in osteomyelitis, Am J Med, 78, 218, 10.1016/0002-9343(85)90388-2 · DOI
  194. Senneville, 2006, Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures, Clin Infect Dis, 42, 57, 10.1086/498112 · DOI · Paper page
  195. Lesens, 2011, Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis, Clin Microbiol Infect, 17, 285, 10.1111/j.1469-0691.2010.03194.x · DOI
  196. Game, 2004, MRSA and osteomyelitis of the foot in diabetes, Diabet Med, 21, 16, 10.1111/j.1464-5491.2004.1424-8.x · DOI
  197. Khatri, 2001, Effect of bone biopsy in guiding antimicrobial therapy for osteomyelitis complicating open wounds, Am J Med Sci, 321, 367, 10.1097/00000441-200106000-00002 · DOI
  198. Slater, 2004, Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone, Diabet Med, 21, 705, 10.1111/j.1464-5491.2004.01221.x · DOI
  199. Zuluaga, 2002, Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study, BMC Infect Dis, 2, 8, 10.1186/1471-2334-2-8 · DOI
  200. Elamurugan, 2011, Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis, Int J Surg, 9, 214, 10.1016/j.ijsu.2010.11.011 · DOI

200 of 332 shown

Cited by

See all 1,766

Metadata

Authors
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J. G., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., Pinzur, M. S., & Senneville, E.
Venue
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
2012-06-15
Volume
54
Issue
12
Pages
e132-e173
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
DOI
10.1093/cid/cis346
OpenAlex
W2135233586
Cited by
1,766
References
7
FWCI
64.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.